首页> 外文OA文献 >Synthesis of Pyrrolo3,4-bpyridin-5-ones via Multicomponent Reactions and In Vitro–In Silico Studies Against SiHa, HeLa, and CaSki Human Cervical Carcinoma Cell Lines
【2h】

Synthesis of Pyrrolo3,4-bpyridin-5-ones via Multicomponent Reactions and In Vitro–In Silico Studies Against SiHa, HeLa, and CaSki Human Cervical Carcinoma Cell Lines

机译:通过多组分反应合成Pyrrolo 3,4-B pyridin-5-吡啶-5-吡啶-5-对Siha,Hela和Caski人宫颈癌细胞系的硅研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of 12 polysubstituted pyrrolo[3,4-b]pyridin-5-ones were synthesized via a one-pot cascade process (Ugi−3CR/aza Diels-Alder/N-acylation/decarboxylation/dehydration) and studied in vitro using human epithelial cervical carcinoma SiHa, HeLa, and CaSki cell line cultures. Three compounds of the series exhibited significative cytotoxicity against the three cell lines, with HeLa being the most sensitive one. Then, based on these results, in silico studies by docking techniques were performed using Paclitaxel as a reference and αβ-tubulin as the selected biological target. Worth highlighting is that strong hydrophobic interactions were observed between the three active molecules and the reference drug Paclitaxel, to the αβ-tubulin. In consequence, it was determined that hydrophobic−aromatic moieties of bioactive compounds and Paclitaxel play a key role in making stronger interactions to the ligand−target complex. A quantitative structure activity relationship (QSAR) study revealed that the six membered rings are the most significant molecular frameworks, being present in all proposed models for the in vitro-studied cell lines. Finally, also from the docking interpretation, a ligand-based pharmacophore model is proposed in order to find further potential polyheterocyclic candidates to bind stronger to the αβ-tubulin.
机译:一系列12取代的吡咯并[3,4-B]吡啶的-5-酮进行了通过一釜级联方法合成(的Ugi-3CR /氮杂狄尔斯 - 阿尔德/ N-酰化/脱羧/脱水)和体外研究使用人上皮宫颈癌的SiHa,HeLa和的CaSki细胞系培养物。该系列的三种化合物表现出有意义的细胞毒性对三种细胞系,HeLa细胞用是最敏感的。然后,基于这些结果,在由对接技术硅研究使用紫杉醇作为参考和αβ微管蛋白作为选定的生物靶标进行。值得强调的是,进行了三个活性分子与参考药物紫杉醇之间观察到很强的疏水性相互作用,与αβ微管蛋白。结果,它被确定生物活性化合物的疏水性芳族结构部分和紫杉醇在使较强的相互作用,以配体 - 靶标复合物中发挥关键作用。的定量结构活性关系(QSAR)研究显示,六元环是最显著分子框架,存在于所有提出的模型用于体外深入研究的细胞系。最后,还从对接解释,基于配体的药效模型,以便找到进一步的潜在候选人多杂环结合更强的αβ微管蛋白建议。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号